{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T01:44:24Z","timestamp":1755999864236,"version":"3.41.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.semnephrol.2024.151495","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:03:03Z","timestamp":1710475383000},"page":"151495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Premalignant Lesions in the Kidney Transplant Candidate"],"prefix":"10.1016","volume":"44","author":[{"given":"Paul M.","family":"Schroder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben E.","family":"Biesterveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Al-Adra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/j.semnephrol.2024.151495_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16982","article-title":"OPTN\/SRTR 2020 annual data report: kidney","volume":"22","author":"Lentine","year":"2022","journal-title":"Am J Transplant"},{"issue":"5 suppl 1","key":"10.1016\/j.semnephrol.2024.151495_bib0002","first-page":"109","article-title":"Evaluation of the candidate with a previous malignancy","volume":"2","author":"Penn","year":"1996","journal-title":"Liver Transpl Surg"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151495_bib0003","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.trre.2017.08.003","article-title":"Cancer recurrence after solid organ transplantation: a systematic review and meta-analysis","volume":"31","author":"Acuna","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151495_bib0004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/TP.0b013e31829854b7","article-title":"Overall and cause-specific mortality in transplant recipients with a pretransplantation cancer history","volume":"96","author":"Brattstrom","year":"2013","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0005","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/ajt.16318","article-title":"Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement","volume":"21","author":"Al-Adra","year":"2021","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0006","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/ajt.16324","article-title":"Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: a consensus expert opinion statement","volume":"21","author":"Al-Adra","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2024.151495_bib0007","article-title":"Skin cancer in solid organ transplant recipients: still an open problem","volume":"10","author":"Granata","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151495_bib0008","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00404-022-06577-2","article-title":"Human papillomavirus anogenital screening in solid organ transplant recipients: a narrative review","volume":"307","author":"Papastamelos","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.semnephrol.2024.151495_bib0009","doi-asserted-by":"crossref","first-page":"782","DOI":"10.12659\/AOT.910658","article-title":"Colonoscopy as part of pre-transplant work-up in successful kidney transplant candidates: single-center experience and review of literature","volume":"23","author":"Kobiela","year":"2018","journal-title":"Ann Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151495_bib0010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.pas.0000126675.59108.80","article-title":"An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms","volume":"28","author":"Hruban","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151495_bib0011","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2214\/AJR.07.3340","article-title":"Prevalence of unsuspected pancreatic cysts on MDCT","volume":"191","author":"Laffan","year":"2008","journal-title":"Am J Roentgenol"},{"issue":"9","key":"10.1016\/j.semnephrol.2024.151495_bib0012","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/ajg.2010.122","article-title":"Prevalence of incidental pancreatic cysts in the adult population on MR imaging","volume":"105","author":"Lee","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0013","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00428-004-1043-z","article-title":"Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal","volume":"445","author":"Kosmahl","year":"2004","journal-title":"Virchows Arch"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151495_bib0014","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/theoncologist.2010-0151","article-title":"Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment","volume":"15","author":"Grutzmann","year":"2010","journal-title":"Oncologist"},{"issue":"92","key":"10.1016\/j.semnephrol.2024.151495_bib0015","doi-asserted-by":"crossref","first-page":"92ra66","DOI":"10.1126\/scitranslmed.3002543","article-title":"Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development","volume":"3","author":"Wu","year":"2011","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151495_bib0016","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151495_bib0017","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1158\/1078-0432.CCR-22-2531","article-title":"Blood-based diagnosis and risk stratification of patients with pancreatic intraductal papillary mucinous neoplasm (IPMN)","volume":"29","author":"Zhang","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151495_bib0018","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.sla.0000128306.90650.aa","article-title":"Intraductal papillary mucinous neoplasms of the pancreas: an updated experience","volume":"239","author":"Sohn","year":"2004","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151495_bib0019","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/01.sla.0000124386.54496.15","article-title":"Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection","volume":"239","author":"Salvia","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/SLA.0b013e31825d355f","article-title":"Small (Sendai negative) branch-duct IPMNs: not harmless","volume":"256","author":"Fritz","year":"2012","journal-title":"Ann Surg"},{"issue":"1-2","key":"10.1016\/j.semnephrol.2024.151495_bib0021","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000090023","article-title":"International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucnous cystic neoplasms of the pancreas","volume":"6","author":"Tanaka","year":"2006","journal-title":"Pancreatology"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151495_bib0022","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pan.2012.04.004","article-title":"International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas","volume":"12","author":"Tanaka","year":"2012","journal-title":"Pancreatology"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151495_bib0023","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cgh.2008.04.005","article-title":"Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm","volume":"6","author":"Tang","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"34","key":"10.1016\/j.semnephrol.2024.151495_bib0024","doi-asserted-by":"crossref","first-page":"9833","DOI":"10.3748\/wjg.v21.i34.9833","article-title":"International guidelines for the management of pancreatic intraductal papillary mucinous neoplasms","volume":"21","author":"Goh","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MPA.0b013e31818786c9","article-title":"Prevalence of pancreatic cystic lesions including intraductal papillary mucinous neoplasms in patients with end-stage renal disease on hemodialysis","volume":"38","author":"Ishikawa","year":"2009","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151495_bib0026","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajt.2022.11.024","article-title":"Prevalence and progression of intraductal papillary mucinous neoplasms of the pancreas in solid organ transplant recipients: a systematic review","volume":"23","author":"Sugawara","year":"2023","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151495_bib0027","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.pan.2016.07.001","article-title":"Chronic immunosuppression does not potentiate the malignant progression of mucinous pancreatic cystic lesions","volume":"16","author":"Agarwal","year":"2016","journal-title":"Pancreatology"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151495_bib0028","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.dld.2015.02.011","article-title":"Prevalence and outcomes of cystic lesion of the pancreas in immunosuppressed patients with solid organ transplantation","volume":"47","author":"Ngamruengphong","year":"2015","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151495_bib0029","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ajg.2009.62","article-title":"Branch duct intraductal papillary mucinous neoplasm of the pancreas in solid organ transplant recipients","volume":"104","author":"Gill","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pan.2018.11.014","article-title":"Systematic review and meta-analysis: prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals","volume":"19","author":"Zerboni","year":"2019","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151495_bib0031","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.pan.2021.04.009","article-title":"Systematic review and meta-analysis of observational studies on BD-IPMNS progression to malignancy","volume":"21","author":"Balduzzi","year":"2021","journal-title":"Pancreatology"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151495_bib0032","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.pan.2013.03.002","article-title":"Enucleation of branch duct-IPMN in a transplant patient","volume":"13","author":"Chiaro","year":"2013","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151495_bib0033","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jcf.2015.03.011","article-title":"Intraductal papillary mucinous neoplasm of the pancreas in an adult patient with cystic fibrosis after double-lung transplantation","volume":"14","author":"Eigner","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0034","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40001-015-0117-5","article-title":"Extensive multifocal branch duct IPMN of the pancreas after liver transplantation: is surgery justified?","volume":"20","author":"Branchi","year":"2015","journal-title":"Eur J Med Res"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151495_bib0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00006676-200405000-00015","article-title":"Intraductal papillary mucinous tumor of the native pancreas in a pancreas-kidney transplant recipient","volume":"28","author":"Jie","year":"2004","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0036","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/ajt.14540","article-title":"Prevalence and outcomes of cystic lesions of the transplant pancreas: the University of Wisconsin experience","volume":"18","author":"Al-Qaoud","year":"2018","journal-title":"Am J Transplant"},{"issue":"26","key":"10.1016\/j.semnephrol.2024.151495_bib0037","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3748\/wjg.v24.i26.2806","article-title":"Current clinical management of gastrointestinal stromal tumor","volume":"24","author":"Akahoshi","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0038","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2005.40709.x","article-title":"The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000","volume":"100","author":"Tran","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151495_bib0039","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.5858\/2006-130-1466-GSTROM","article-title":"Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis","volume":"130","author":"Miettinen","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pas.0000146010.92933.de","article-title":"Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up","volume":"29","author":"Miettinen","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"9896","key":"10.1016\/j.semnephrol.2024.151495_bib0041","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(13)60106-3","article-title":"Gastrointestinal stromal tumour","volume":"382","author":"Joensuu","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151495_bib0042","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s11604-022-01305-x","article-title":"Gastrointestinal stromal tumors: a comprehensive radiological review","volume":"40","author":"Inoue","year":"2022","journal-title":"Jpn J Radiol"},{"issue":"14","key":"10.1016\/j.semnephrol.2024.151495_bib0043","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3748\/wjg.v13.i14.2077","article-title":"Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration","volume":"13","author":"Akahoshi","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0044","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gie.2006.02.027","article-title":"Yield of tissue sampling for subepithelial lesions evaluated by EUS: a comparison between forceps biopsies and endoscopic submucosal resection","volume":"64","author":"Cantor","year":"2006","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jcp.54.2.96","article-title":"The histopathological differential diagnosis of gastrointestinal stromal tumours","volume":"54","author":"Graadt van Roggen","year":"2001","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0046","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0002-9440(10)63279-8","article-title":"The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status","volume":"165","author":"West","year":"2004","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151495_bib0047","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.humpath.2008.06.025","article-title":"Risk stratification of patients diagnosed with gastrointestinal stromal tumor","volume":"39","author":"Joensuu","year":"2008","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151495_bib0048","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1470-2045(11)70299-6","article-title":"Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts","volume":"13","author":"Joensuu","year":"2012","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151495_bib0049","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.2012.347","article-title":"One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial","volume":"307","author":"Joensuu","year":"2012","journal-title":"JAMA"},{"issue":"9440","key":"10.1016\/j.semnephrol.2024.151495_bib0050","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","article-title":"Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomized trial","volume":"364","author":"Verweij","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151495_bib0051","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1200\/JCO.2007.13.4452","article-title":"Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033","volume":"26","author":"Blanke","year":"2008","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.semnephrol.2024.151495_bib0052","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM200104053441404","article-title":"Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor","volume":"344","author":"Joensuu","year":"2001","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151495_bib0053","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/ndt\/16.7.1517","article-title":"Renal failure and nephrotic syndrome associated with gastrointestinal stromal tumour (GIST)\u2014a rare cause of AA amyloidosis","volume":"16","author":"Jaakkola","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151495_bib0054","first-page":"620","article-title":"Chronic renal failure secondary to systemic amyloidosis associated with gastrointestinal stromal tumour","volume":"33","author":"Muniz-Pacios","year":"2013","journal-title":"Nefrologia"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151495_bib0055","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/jso.25080","article-title":"The association of renal cell carcinoma with gastrointestinal stromal tumors","volume":"117","author":"Mendoca","year":"2018","journal-title":"J Surg Oncol"},{"issue":"23","key":"10.1016\/j.semnephrol.2024.151495_bib0056","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2024.151495_bib0057","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-207178","article-title":"Gastrointestinal stromal tumour in a recipient with kidney transplantation","volume":"2015","author":"Cimen","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151495_bib0058","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ndt\/gfl807","article-title":"Gastrointestinal stromal tumours (GIST) in kidney tranpslnat recipients\u2014a report of two cases","volume":"22","author":"Agaimy","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0059","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s10157-011-0550-x","article-title":"Extragastrointestinal stromal tumor in a kidney transplant recipient","volume":"16","author":"Tu","year":"2012","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12882-019-1310-5","article-title":"Small intestinal perforation due to a huge gastrointestinal stromal tumor in a kidney transplant recipient: a case report and literature review","volume":"20","author":"Takahashi","year":"2019","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0061","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ajco.12506","article-title":"Gastrointestinal stromal tumors in kidney transplant recipients: report of two cases and literature review","volume":"13","author":"Cheung","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"issue":"34","key":"10.1016\/j.semnephrol.2024.151495_bib0062","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.3748\/wjg.v28.i34.5076","article-title":"Gastrointestinal tumors in transplantation: two case reports and review of literature","volume":"28","author":"Stammler","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151495_bib0063","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1007\/s10637-011-9769-3","article-title":"Renal dysfunction in a renal transplant patient treated concurrently with cyclosporine and imatinib","volume":"30","author":"Mulder","year":"2012","journal-title":"Invest New Drugs"},{"issue":"22","key":"10.1016\/j.semnephrol.2024.151495_bib0064","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.18632\/oncotarget.2607","article-title":"MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors","volume":"5","author":"Hsueh","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151495_bib0065","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151495_bib0066","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00000658-199910000-00012","article-title":"Clinical and pathologic predictors of survival in patients with thymoma","volume":"230","author":"Wilkins","year":"1999","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151495_bib0067","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jtcvs.2005.07.026","article-title":"Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size","volume":"130","author":"Wright","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151495_bib0068","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.athoracsur.2008.12.095","article-title":"Thymomas: review of current clinical practice","volume":"87","author":"Tomaszek","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151495_bib0069","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.21037\/jtd-2019-thym-01","article-title":"Classification and staging of thymoma","volume":"12","author":"Markowiak","year":"2020","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.2012.484","article-title":"Glomerular diseases seen with cancer and chemotherapy: a narrative review","volume":"84","author":"Jhaveri","year":"2013","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0071","first-page":"27","article-title":"Minimal change disease as a paraneoplastic manifestation of solid malignant tumors","volume":"4","author":"Yong","year":"2012","journal-title":"Neph Res Rev"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151495_bib0072","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/1759-7714.13936","article-title":"Urgent lung transplantation for thymic neoplasm-associated severe constrictive bronchiolitis with bronchiectasis and radiotherapy-induced organizing pneumonia: a case report","volume":"12","author":"Stupnik","year":"2021","journal-title":"Thorac Cancer"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0073","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.lungcan.2012.03.014","article-title":"Thymoma and solid-organ transplantation","volume":"77","author":"Guibert","year":"2012","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151495_bib0074","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.21037\/jtd.2019.09.85","article-title":"Comparison between thoracoscopic and open approaches in thymoma resection","volume":"11","author":"Wang","year":"2019","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0075","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1038\/s41467-018-06498-2","article-title":"ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup","volume":"9","author":"Chan","year":"2018","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151495_bib0076","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/oncolo\/oyac049","article-title":"Incidence patterns of pancreatic neuroendocrine tumors over the last 2 decades: a SEER database analysis","volume":"27","author":"Sonbol","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.semnephrol.2024.151495_bib0077","unstructured":"National Cancer Comprehensive Network. Neuroendocrine and adrenal tumors (version 1.2023). Accessed July 17, 2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/neuroendocrine.pdf"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151495_bib0078","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/MPA.0b013e3181f3a681","article-title":"Pathological incidence of duodenopancreatic neuroendocrine tumors in the Netherlands: a Pathologisch Anatomisch Landelijk Geautomatiseerd Archief study","volume":"39","author":"Kuiper","year":"2010","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0079","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00535-014-0934-2","article-title":"Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis","volume":"50","author":"Ito","year":"2015","journal-title":"J Gastroenterol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5858\/arpa.2013-0520-RS","article-title":"Endocrine manifestations of von Hippel-Lindau disease","volume":"139","author":"Cassol","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151495_bib0081","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/MPA.0000000000001597","article-title":"The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors","volume":"49","author":"Halfdanarson","year":"2020","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0082","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jso.25481","article-title":"Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: an analysis from the U.S. Neuroendocrine Tumor Study Group","volume":"120","author":"Zhang","year":"2019","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0083","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.semnephrol.2024.151495_bib0084","unstructured":"US Department of Health and Human Services. Guidance to liver transplant programs and the National Liver Review Board for: adult MELD exception review. Accessed July 15, 2023. https:\/\/optnpilot.unos.org\/media\/2847\/liver_guidance_adult_meld_201706.pdf"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151495_bib0085","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","article-title":"The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151495_bib0086","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00268-017-4278-y","article-title":"A nationwide population-based study on the survival of patients with pancreatic neuroendocrine tumors in the Netherlands","volume":"42","author":"Genc","year":"2018","journal-title":"World J Surg"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151495_bib0087","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MNM.0000000000000874","article-title":"177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update","volume":"39","author":"Demirci","year":"2018","journal-title":"Nucl Med Commun"},{"issue":"18","key":"10.1016\/j.semnephrol.2024.151495_bib0088","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151495_bib0089","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/jamaoncol.2018.0024","article-title":"Recurrence in resected gastroenteropancreatic neuroendocrine tumors","volume":"4","author":"Singh","year":"2018","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151495_bib0090","doi-asserted-by":"crossref","first-page":"e13205","DOI":"10.1111\/jne.13205","article-title":"Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence-free survival","volume":"34","author":"Daskalakis","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0091","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/ERC-17-0269","article-title":"Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame","volume":"25","author":"Marotta","year":"2018","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151495_bib0092","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1097\/MPA.0000000000000610","article-title":"Transcriptomic profiling of tumor aggressiveness in sporadic nonfunctioning pancreatic neuroendocrine neoplasms","volume":"45","author":"Haugvik","year":"2016","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151495_bib0093","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.surg.2012.08.038","article-title":"Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management","volume":"152","author":"Lee","year":"2012","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151495_bib0094","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1245\/s10434-015-4986-1","article-title":"Observation versus resection for small asymptomatic pancreatic neuroendocrine tumors: a matched case\u2013control study","volume":"23","author":"Sadot","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151495_bib0095","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/bjs\/znab088","article-title":"Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA)","volume":"108","author":"Heidsma","year":"2021","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151495_bib0096","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/archsurg.2011.102","article-title":"Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes","volume":"146","author":"Haynes","year":"2011","journal-title":"Arch Surg"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151495_bib0097","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s11605-017-3365-6","article-title":"Pancreatic neuroendocrine tumors (panNETs): analysis of overall survival of nonsurgical management versus surgical resection","volume":"21","author":"Finkelstein","year":"2017","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151495_bib0098","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hpb.2017.08.034","article-title":"Prognosis of sporadic resected small (\u22642 cm) nonfunctional pancreatic neuroendocrine tumors\u2014a multi-institutional study","volume":"20","author":"Sallinen","year":"2018","journal-title":"HPB (Oxford)"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151495_bib0099","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.hpb.2018.09.020","article-title":"Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association","volume":"21","author":"Mansour","year":"2019","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","article-title":"The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors","volume":"49","author":"Howe","year":"2020","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151495_bib0101","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/qjmed\/hcac036","article-title":"Effects of transplantation-related immunosuppression on co-existent neuroendocrine tumours","volume":"115","author":"Shah","year":"2022","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151495_bib0102","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13139-014-0297-x","article-title":"Metastatic neuroendocrine tumour in a renal transplant recipient: dual-tracer PET-CT with (18)F-FDG and (68)Ga-DOTANOC in this rare setting","volume":"49","author":"Karunanithi","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151495_bib0103","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929524000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929524000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:51:17Z","timestamp":1748357477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929524000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0270929524000123"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151495","relation":{},"ISSN":["0270-9295"],"issn-type":[{"type":"print","value":"0270-9295"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Premalignant Lesions in the Kidney Transplant Candidate","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151495"}}